Company / SG&A per Share
Kodiak Sciences Inc. SG&A per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.16
FY2024
5-year range
$0.63 / $1.41
FY2020-FY2024
Trend
-14.7%
vs FY2023
Sector context
#112 of 208
Health Care
What the data says
At $1.16, Kodiak Sciences Inc.'s sg&a per share ranks #97 of 208 in the Health Care sector. SG&A per Share has fluctuated over the past 9 years, ranging from $0.31 in FY2019 to $1.41 in FY2022.
Based on SEC 10-K filings.
1.16 in FY2024 with a 5-year CAGR of +30.2%.
Improved from $1.41 to $1.16 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +6.4%
- 5-Year CAGR
- +30.2%
- 10-Year CAGR
- -
Sector benchmark
#97 of 208 in Health CareTop 46% of 208This company $1.16 Sector average $29.78
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share decreased 14.7% year-over-year.
- Ranks #112 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.16 | -14.7% |
| FY2023 | $1.36 | -4.0% |
| FY2022 | $1.41 | +47.1% |
| FY2021 | $0.96 | +53.4% |
| FY2020 | $0.63 | +102.7% |
| FY2019 | $0.31 | -39.0% |
| FY2018 | $0.51 | +8.7% |
| FY2017 | $0.47 | +8.4% |
| FY2016 | $0.43 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026